8-KOther EventsExhibits & Filings

AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Jul 13, 2010)

Filed July 13, 2010For Securities:A

Summary

Agilent Technologies, Inc. filed this Form 8-K on July 13, 2010, primarily to incorporate revised information into future registration statements. The key update concerns the company's organizational structure, specifically the formation of three new operating segments: Life Sciences, Chemical Analysis, and Electronic Measurement. These new segments replace the previous structure where bio-analytical measurement was split into two, and electronic measurement was recombined with semiconductor and board test. This restructuring involved recasting historical segment data to align with the new reporting framework. While this 8-K provides the framework for these changes and incorporates revised sections of the company's 2009 Form 10-K, it explicitly states that it does not update Management's Discussion and Analysis for subsequent events. Investors are directed to the Form 10-Q for the period ended April 30, 2010, and other filings for more current information regarding the company's financial condition and operational updates.

Key Highlights

  • 1Agilent Technologies has reorganized into three new operating segments: Life Sciences, Chemical Analysis, and Electronic Measurement.
  • 2Historical segment financial data has been recast to reflect the new three-segment structure.
  • 3This 8-K filing is primarily for incorporating these structural changes into future registration statements.
  • 4Revised sections of the 2009 Form 10-K, including Business, Risk Factors, and Financial Data, are included as exhibits.
  • 5The filing clarifies that it does not update subsequent financial information or events; investors should refer to the latest Form 10-Q for current details.
  • 6The company has also filed its Computation of Ratio of Earnings to Fixed Charges for relevant periods.

Frequently Asked Questions

The primary purpose of this Form 8-K is to officially incorporate the company's revised business segment structure and related recast financial data into its filings, particularly for use in future registration statements. It serves to formally document these organizational changes and their impact on reporting.

Agilent Technologies has reorganized its business into three operating segments: Life Sciences, Chemical Analysis, and Electronic Measurement. This represents a consolidation and refinement of its previous segment reporting structure.

No, this filing does not provide updated financial performance or outlook. It specifically states that it does not update the Management's Discussion and Analysis for events occurring after the filing of the 2009 Form 10-K. Investors seeking the most current financial information and operational updates should consult Agilent's Form 10-Q for the period ended April 30, 2010, and other subsequent SEC filings.

The revisions to the 2009 Form 10-K included in this filing as Exhibit 99.1 pertain to Item 1 (Business), Item 1A (Risk Factors), Item 2 (Properties), Item 6 (Selected Financial Data), Item 7 (Management’s Discussion and Analysis of Financial Condition and Results of Operations), Item 8 (Financial Statements and Supplementary Data), and Item 15 (Exhibits and Financial Statement Schedules). These revisions are solely to reflect the new operating segment structure.